CDMOs offering Oral Solid Dosage Manufacturing with Small Molecule in United States
13 matching organizations
Oral Solid Dosage Manufacturing with Small Molecule in United States is a frequent shortlist pattern for sponsors evaluating CDMO partners with regional footprint. This page lists organizations that map to all three dimensions so you can move from broad taxonomy browsing to a geography-aware candidate set.
Profiles emphasize fit-first discovery: review scope, regulatory posture, and provenance on each listing rather than treating this page as a single ranked recommendation.
When you need additional filters (indications, claim status, or free-text search), continue to the main search experience and layer criteria on top of this starting point.
- Almac Group
Global CDMO with 7,900+ employees across 18 facilities, offering integrated drug development and manufacturing services including analytical development, formulation, process development, fill-finish, and specialized chemistry capabilities.
- Ascendia Pharmaceutical Solutions
Specialty CDMO offering formulation development, analytical services, and cGMP manufacturing for small molecules and biologics from preclinical through Phase 1 and commercialization.
- BSP Pharmaceuticals
CDMO specializing in cytotoxic and high-potency oncology drugs, ADCs, peptides, proteins, oligonucleotides, and lipid-based formulations with GLP development through cGMP commercial manufacturing across segregated high-containment facilities.
- Bend Bioscience
U.S. pharmaceutical CDMO offering design, development, and manufacturing from early formulation to commercial-scale production, with cGMP capabilities including spray drying, particle engineering, and complex oral dosage forms.
- Catalent
Leading global CDMO offering end-to-end development and manufacturing for pharma, biotech, and consumer health—spanning oral dose, biologics, cell and gene therapies, clinical supply, and specialty formulations with advanced technologies and worldwide GMP capacity.
- JRS Pharma
JRS Pharma provides innovative excipients, coatings, formulation expertise, and biopharma services for solid and liquid dosage form development and manufacturing.
- Metrics Contract Services
Metrics Contract Services, acquired by Catalent in 2024 for $475 million, operates a state-of-the-art facility in Greenville, North Carolina specializing in oral solid formulation development, manufacturing, and packaging. The organization brings over 20 years of experience…
- Patheon (Thermo Fisher Pharma Services)
Global CDMO partner offering 360° integrated drug development solutions from early-stage R&D through clinical supply and commercial manufacturing for biologics and small molecules.
- PharmaBlock
Leading provider of innovative chemistry products and services for pharmaceutical R&D and commercial manufacturing, with expertise in process development, GMP manufacturing, and low-carbon chemistry solutions.
- Pharmaceutics International, Inc.
Drug product CDMO specializing in aseptic injectables, oral solid dose, lyophilization, and prefilled syringes with 30+ years of experience in complex formulations and potent compounds; now part of Jabil.
- Pharmaron
Premier life science CRO and CDMO offering integrated R&D and manufacturing across drug discovery, preclinical, clinical development, and commercialization for small molecules, biologics, and cell & gene therapies. 25,000+ employees across China, US, and UK.
- Quotient Sciences
Integrated CDMO offering drug product formulation and manufacturing for small molecules and synthetic peptides, with 30+ years of experience and scalable capacity from clinical to 500 kg commercial batches across US and UK facilities.
- Syngene International
Innovation-led CRDMO offering integrated scientific services from early discovery through commercial manufacturing, with cGMP-compliant facilities, 5,200+ scientists, and a new 50,000-liter single-use bioreactor capacity in the U.S.
Markdown mirror: /explore/svc_oral_solid_dosage/mod_small_molecule/us.md